Emergent BioSolutions (EBS) Misses Q3 EPS by 3c, FY Revenue Guidance Beats
Go back to Emergent BioSolutions (EBS) Misses Q3 EPS by 3c, FY Revenue Guidance Beats| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 8.01 +0.16 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.85 | 52 Week High | $44.38 | |||
| Open | $7.80 | 52 Week Low | $24.47 | |||
| Day High | $8.07 | P/E | 400.50 | |||
| Day Low | $7.80 | EPS | $0.02 | |||
| Volume | 838,714 | |||||
